EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 141 filers reported holding EAGLE PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.34 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $2,464,000 | +80.5% | 35,200 | 0.0% | 0.84% | +53.8% |
| Q2 2016 | $1,365,000 | -4.3% | 35,200 | 0.0% | 0.55% | -7.8% |
| Q1 2016 | $1,426,000 | -54.3% | 35,200 | 0.0% | 0.59% | -32.6% |
| Q4 2015 | $3,121,000 | -64.8% | 35,200 | -70.6% | 0.88% | -48.3% |
| Q3 2015 | $8,876,000 | -22.3% | 119,900 | -15.1% | 1.70% | +57.7% |
| Q2 2015 | $11,426,000 | +68.3% | 141,300 | -12.8% | 1.08% | +68.0% |
| Q1 2015 | $6,790,000 | +119.0% | 162,100 | -19.0% | 0.64% | +115.8% |
| Q4 2014 | $3,100,000 | +22.5% | 200,000 | 0.0% | 0.30% | +13.8% |
| Q3 2014 | $2,530,000 | -11.7% | 200,000 | 0.0% | 0.26% | +6.1% |
| Q2 2014 | $2,866,000 | +12.4% | 200,000 | 0.0% | 0.25% | +18.3% |
| Q1 2014 | $2,550,000 | – | 200,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 94,922 | $4,063,000 | 1.33% |
| Smith, Graham & Co., Investment Advisors, LP | 277,572 | $11,880,000 | 1.05% |
| Krensavage Asset Management, LLC | 70,804 | $3,030,000 | 1.03% |
| BRANDES INVESTMENT PARTNERS, LP | 716,873 | $30,682,000 | 0.68% |
| GLOBEFLEX CAPITAL L P | 42,357 | $1,813,000 | 0.33% |
| Zebra Capital Management LLC | 6,472 | $277,000 | 0.32% |
| Capital Impact Advisors, LLC | 19,276 | $825,000 | 0.27% |
| Hein Park Capital Management LP | 31,977 | $1,369,000 | 0.26% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 195,340 | $8,361,000 | 0.25% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,027,000 | 0.15% |